Associate Director, Market Access and Value Evidence Strategy; Remote

What if the work you did every day could impact the lives of people you know? Or all of humanity? At Illumina, we are expanding access to genomic technology to realize health equity for billions of people around the world. Our efforts enable life‑changing discoveries that are transforming human health through the early detection and diagnosis of diseases and new treatment options for patients.

Working at Illumina means being part of something bigger than yourself. Every person, in every role, has the opportunity to make a difference. Surrounded by extraordinary people, inspiring leaders, and world changing projects, you will do more and become more than you ever thought possible.

At Illumina, we are dedicated to improving human health by unlocking the power of the genome. As the Associate Director, Market Access and Value Evidence Strategy, you will support regional and global access strategies for our portfolio of molecular diagnostic solutions in oncology, adult and pediatric genetic disease, reproductive health, as well as a portfolio of emerging applications. Your work will help ensure that individuals and families around the world can benefit from access to genomic insights.

This is a key role that requires expertise in diagnostic testing and the molecular diagnostic ecosystem. You will collaborate across regions and functions to shape the value narrative, support market access and reimbursement initiatives, and drive adoption through partnership of Illumina technologies in healthcare systems.

• Support US and global market access strategies for molecular diagnostic solutions including client and ecosystem facing partnerships and internal development processes.

• Partner with regional and country teams to secure reimbursement and access in key markets, addressing diverse payer requirements and Health Technology Assessment processes.

• Collaborate with regional Government Affairs, Commercial, Medical Affairs and Marketing teams to support strategies to gain, protect and expand access to genomic solutions and emerging applications.

• Support the definition and communication of clinical and economic value of diagnostics through compelling value propositions, evidence generation studies, and payer engagement and collaboration.

• Lead the creation of US payer‑agnostic and payer‑specific market access strategies for key Illumina applications including identification of key resources required, value messaging, and clinical and economic data gaps.

• Aid in monitoring US and global policy coverage trends, rate setting, HTA requirements, and payer expectations related to molecular diagnostic testing to inform strategic planning and product development.

• Aid in the development of global value dossiers, reimbursement toolkits, and payer engagement materials to support local execution.

• In collaboration with regional Market Access, build and maintain relationships with external stakeholders, including payers, HTA bodies, advocacy groups, and policy makers.

• Maintain positive working relationships across key channels including customers, distributors, and core laboratories. Support Commercial and Marketing, as needed, in engagements including conferences and customer engagement.

• Provide strategic input into product development, launch planning, customer channel considerations and lifecycle management to align with access and commercialization goals.

• Ensure compliance with company, international regulatory, legal, and ethical standards.

• Bachelor’s degree required; advanced degree (GC, MBA, MPH, PhD, or related) preferred.

• 15 years with 7+ years of management experience in clinical setting, market access, reimbursement, and/or health economics, with a strong focus on molecular diagnostics.

• Proven success in market access strategies and partnering in diagnostics, biopharma, or the payer setting.

• Understanding of reimbursement systems, HTA processes, and payer decision‑making across major markets.

• Experience with molecular diagnostics, next‑generation sequencing (NGS), and precision medicine applications.

• Strong leadership, strategic thinking, and cross‑functional collaboration…